A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors
Clinical trial NCT06389526 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06389526
- Sponsor
- Coherus Oncology, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-15
- Primary completion
- 2028-05-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.